1-156815825-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003975.4(SH2D2A):​c.123+181C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,613,396 control chromosomes in the GnomAD database, including 370,132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 31223 hom., cov: 31)
Exomes 𝑓: 0.68 ( 338909 hom. )

Consequence

SH2D2A
NM_003975.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.84

Publications

30 publications found
Variant links:
Genes affected
SH2D2A (HGNC:10821): (SH2 domain containing 2A) This gene encodes an adaptor protein thought to function in T-cell signal transduction. A related protein in mouse is responsible for the activation of lymphocyte-specific protein-tyrosine kinase and functions in downstream signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
NTRK1 (HGNC:8031): (neurotrophic receptor tyrosine kinase 1) This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]
NTRK1 Gene-Disease associations (from GenCC):
  • hereditary sensory and autonomic neuropathy type 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-156815825-G-A is Benign according to our data. Variant chr1-156815825-G-A is described in ClinVar as [Benign]. Clinvar id is 380853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH2D2ANM_003975.4 linkc.123+181C>T intron_variant Intron 2 of 8 ENST00000368199.8 NP_003966.2 Q9NP31-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH2D2AENST00000368199.8 linkc.123+181C>T intron_variant Intron 2 of 8 1 NM_003975.4 ENSP00000357182.3 Q9NP31-1

Frequencies

GnomAD3 genomes
AF:
0.635
AC:
96440
AN:
151824
Hom.:
31197
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.505
Gnomad AMI
AF:
0.798
Gnomad AMR
AF:
0.695
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.819
Gnomad SAS
AF:
0.646
Gnomad FIN
AF:
0.661
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.645
GnomAD2 exomes
AF:
0.674
AC:
169366
AN:
251274
AF XY:
0.676
show subpopulations
Gnomad AFR exome
AF:
0.499
Gnomad AMR exome
AF:
0.695
Gnomad ASJ exome
AF:
0.698
Gnomad EAS exome
AF:
0.818
Gnomad FIN exome
AF:
0.649
Gnomad NFE exome
AF:
0.677
Gnomad OTH exome
AF:
0.669
GnomAD4 exome
AF:
0.679
AC:
992629
AN:
1461454
Hom.:
338909
Cov.:
57
AF XY:
0.679
AC XY:
493795
AN XY:
727032
show subpopulations
African (AFR)
AF:
0.491
AC:
16422
AN:
33470
American (AMR)
AF:
0.693
AC:
31008
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.689
AC:
18018
AN:
26134
East Asian (EAS)
AF:
0.817
AC:
32421
AN:
39698
South Asian (SAS)
AF:
0.657
AC:
56669
AN:
86236
European-Finnish (FIN)
AF:
0.650
AC:
34732
AN:
53414
Middle Eastern (MID)
AF:
0.719
AC:
4148
AN:
5766
European-Non Finnish (NFE)
AF:
0.682
AC:
758001
AN:
1111638
Other (OTH)
AF:
0.682
AC:
41210
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
18093
36185
54278
72370
90463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19478
38956
58434
77912
97390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.635
AC:
96511
AN:
151942
Hom.:
31223
Cov.:
31
AF XY:
0.640
AC XY:
47513
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.506
AC:
20947
AN:
41422
American (AMR)
AF:
0.696
AC:
10621
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2369
AN:
3468
East Asian (EAS)
AF:
0.819
AC:
4213
AN:
5146
South Asian (SAS)
AF:
0.647
AC:
3120
AN:
4822
European-Finnish (FIN)
AF:
0.661
AC:
6988
AN:
10566
Middle Eastern (MID)
AF:
0.714
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
0.677
AC:
45960
AN:
67934
Other (OTH)
AF:
0.643
AC:
1357
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1732
3464
5196
6928
8660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
790
1580
2370
3160
3950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.665
Hom.:
143032
Bravo
AF:
0.635
Asia WGS
AF:
0.702
AC:
2441
AN:
3478
EpiCase
AF:
0.678
EpiControl
AF:
0.682

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 07, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

X-linked lymphoproliferative disease due to SH2D1A deficiency Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary insensitivity to pain with anhidrosis Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.50
DANN
Benign
0.78
PhyloP100
-1.8
PromoterAI
-0.030
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800601; hg19: chr1-156785617; COSMIC: COSV63884607; COSMIC: COSV63884607; API